ClinicalTrials.gg
CompletedNCT05376787Updated Oct 17, 2024Results posted

Verify the Performance of the Neutral Electrode (NE) Adhesives

An observational study in Adhesion of the Neutral Electrode 21pad, sponsored by Medline Industries. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2024-10-17.

Sponsored by Medline Industries · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
20
Sex
All
01

Study summary

The purpose of this research study is to determine the neutral electrode 21pad adhesion to the skin in accordance with international standard IEC 60601-2-2 section 201.15.101.7. A neutral electrode is placed on the body of patients undergoing surgery that involves the use of electric current, to protect them from the harmful effects of the electricity.

Read the detailed description

Two neutral electrodes will be applied to the front of your thighs. The study staff will set up and attach a pulley system to the neutral electrodes. The purpose of the pulley system is to apply a force pulling the neutral electrode away from your body. The force will be applied for 10 minutes on each neutral electrode in one direction, and then for another 10 minutes in a second direction. Site staff will mark any areas of separation and the neutral electrodes will be removed.

02

Conditions studied

  • Adhesion of the Neutral Electrode 21pad
03

In context

Lead sponsor

Medline Industries is the lead sponsor of 39 studies on the registry; none are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 14 (93%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Study population will consist of at least 10 males and 10 females. Participants must be healthy and of at least 18 years of age. Participants must also fit inclusion and exclusion criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be willing to comply with all study procedures
  • Participants must be willing to shave, or to have shaved, the sites where the neutral electrodes will be placed.

Exclusion criteria

Exclusion Criteria:

  • The participant has any skin conditions (e.g. eczema, sensitivities, allergies to adhesives, sunburn, etc.) at the application sites that might be adversely affected by the application of an adhesive pad.
  • The participant is pregnant or breastfeeding.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy Subjects

    Participants must be willing to comply with all study procedures Participants must be willing to shave, or to have shaved, the sites where the neutral electrodes will be placed.

    Device: Medline NE Grounding Pad

Interventions

  • DeviceMedline NE Grounding Pad

    Split Universal Grounding Pads

06

What researchers measure

Primary outcomes

  1. Number of Tests With No More Than 5% Separation - Neutral Electrode (NE) Adhesive Separation

    To determine the percentage of adhesion separation by only measuring test results that had no more than 5% of the NE adhesive area separated. At Point A where the NE connects to the pad, connect a cord to pull on the cable. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad and in a direction away from the center of the pad, with 10 to 11N (1.02 to 1.12kg) of force in the direction along the minor dimension of the pad. Set the height of the pulley so that the direction of pull shall be approximately co-planer with the plane of the connection point of the NE. The pull shall be performed by a cord connected to the NE at the cable connection point. See Figure 2 for the pull set up. The weights provide the required pull force. Start timer. At 10 mins, change direction of pull to y direction by rotating the pulley system 90 degrees as shown in Figure 2 - apply 10 to 11 N force at Point A in direction of y ray which is in a plane parallel to the pad. Start timer. At 10 mins

    Time frame: Up to 20 minutes - (10 minutes w. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad & At 10 mins, change direction of pull to y direction)

07

Results

Posted Oct 17, 2024

Participant flow

Participant flow — Overall Study
MilestoneHealthy Subjects
Started20
Completed20
Not completed0

Outcome measures

PrimaryNumber of Tests With No More Than 5% Separation - Neutral Electrode (NE) Adhesive Separation

To determine the percentage of adhesion separation by only measuring test results that had no more than 5% of the NE adhesive area separated. At Point A where the NE connects to the pad, connect a cord to pull on the cable. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad and in a direction away from the center of the pad, with 10 to 11N (1.02 to 1.12kg) of force in the direction along the minor dimension of the pad. Set the height of the pulley so that the direction of pull shall be approximately co-planer with the plane of the connection point of the NE. The pull shall be performed by a cord connected to the NE at the cable connection point. See Figure 2 for the pull set up. The weights provide the required pull force. Start timer. At 10 mins, change direction of pull to y direction by rotating the pulley system 90 degrees as shown in Figure 2 - apply 10 to 11 N force at Point A in direction of y ray which is in a plane parallel to the pad. Start timer. At 10 mins

Time frame:
Up to 20 minutes - (10 minutes w. Pull for 10 to 10.25 minutes, in a plane parallel to the NE pad & At 10 mins, change direction of pull to y direction)
Reported as:
Number · Tests
Number of Tests With No More Than 5% Separation - Neutral Electrode (NE) Adhesive Separation
TestsHealthy Subjects
Number of Tests With No More Than 5% Separation - Neutral Electrode (NE) Adhesive Separation39

Adverse events

Collected over Up to 20 minutes. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Healthy Subjects0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Healthy Subjects
<=18 years20
Between 18 and 65 years0
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Healthy Subjects
Female10
Male10
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Healthy Subjects
Region of Enrollment
Region of Enrollment(participants)Healthy Subjects
United States20
08

Study locations

1 site
  • F2 Labs
    Damascus, Maryland 20872, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · May 30, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05376787
Lead sponsor
Medline Industries
Collaborators
F2 Labs
Responsible party
Sponsor
First posted
May 17, 2022
Start date
May 30, 2022
Primary completion
Jun 10, 2022
Completion
Jun 10, 2022
Results posted
Oct 17, 2024
Last update
Oct 17, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion